Compare Medline Inc. Class A Common Stock (MDLN) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medline Inc. Class A Common Stock vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Medline Inc. Class A Common Stock trades at $36.15 (market cap $31.36B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.69 (market cap $2.27B). The key difference: Medline Inc. Class A Common Stock is far larger — about 13.8× SELLAS Life Sciences Group Inc. Common Stock's market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, Medline Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals.
| MDLN | SLS | |
|---|---|---|
Market Cap | $31.36B | $2.27B |
Volume | 10,191,251 | 4,179,659 |
Sector | Health | Health |
52-Week High | $49.99 | $15.46 |
52-Week Low | $31.64 | $1.39 |
Typical Hold Time | 1 Days | — |
Enterprise Value | $41.32B | $2.14B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Medline Inc. Class A Common Stock
Medline provides medical-surgical products and supply-chain solutions for healthcare providers. Its portfolio and distribution network serve hospitals, clinics, long-term care facilities, and other care settings.
Read more on MDLN →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
